Literature DB >> 8431376

High-dose folinic acid with 5-fluorouracil bolus and continuous infusion in the treatment of advanced gastric and oesophageal adenocarcinoma.

M S Highley, M E Hill, N Ziras, N Samandas, R C Mason, W Owen, J Dussek, S Barker, P G Harper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8431376      PMCID： PMC1968156          DOI： 10.1038/bjc.1993.75

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  6 in total

1.  High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer.

Authors:  C Louvet; A de Gramont; B Demuynck; B Nordlinger; J E Maisani; B Lagadec; S Delfau; C Varette; G Gonzalez-Canali; M Krulik
Journal:  Ann Oncol       Date:  1991-03       Impact factor: 32.976

2.  High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.

Authors:  A De Gramont; M Krulik; J Cady; B Lagadec; J E Maisani; J P Loiseau; J D Grange; G Gonzalez-Canali; B Demuynck; C Louvet
Journal:  Eur J Cancer Clin Oncol       Date:  1988-09

3.  Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.

Authors:  D Machover; E Goldschmidt; P Chollet; G Metzger; J Zittoun; J Marquet; J M Vandenbulcke; J L Misset; L Schwarzenberg; J B Fourtillan
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

4.  A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.

Authors:  C Erlichman; S Fine; A Wong; T Elhakim
Journal:  J Clin Oncol       Date:  1988-03       Impact factor: 44.544

5.  A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma.

Authors:  S G Arbuck; H O Douglass; F Trave; S Milliron; M Baroni; H Nava; L J Emrich; Y M Rustum
Journal:  J Clin Oncol       Date:  1987-08       Impact factor: 44.544

6.  A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas.

Authors:  P W Johnson; P I Thompson; M T Seymour; N P Deasy; R C Thuraisingham; M L Slevin; P F Wrigley
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640
  6 in total
  2 in total

1.  Palliation of malignant dysphagia: an alternative to surgery.

Authors:  R Mason
Journal:  Ann R Coll Surg Engl       Date:  1996-09       Impact factor: 1.891

2.  Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer.

Authors:  T Conroy; F Viret; E François; J F Seitz; V Boige; M Ducreux; M Ychou; J P Metges; M Giovannini; Y Yataghene; D Peiffert
Journal:  Br J Cancer       Date:  2008-10-07       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.